Dr. Charles Burger, MD

Dr. Burger practices at Mayo Clinic Hospital in Jacksonville, Florida, part of Mayo Clinic.

Dr. Burger's NPI, 1790772671, was assigned on October 5, 2005. Dr. Burger graduated from Wake Forest School of Medicine in 1985. Dr. Burger holds Florida license ME57557.

Dr. Burger's primary practice is Mayo Clinic Hospital, at 4500 San Pablo Rd, Jacksonville, FL 32224 in Duval County. The practice phone is (904) 953-2000.

Dr. Burger's primary practice is Mayo Clinic Hospital in Jacksonville, Florida, part of Mayo Clinic. The medical group on file is Mayo Clinic Jacksonville.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Burger practices. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Burger's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Burger is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Burger's licenses on file in 6 states: Florida, Georgia, Kentucky, Minnesota, Iowa and Tennessee.

Dmand AI lists asthma, bronchitis, chronic lung disease, chronic obstructive pulmonary disease (COPD), pneumonia and pulmonary heart disease among the conditions Dr. Burger treats.

CMS data shows 127 Medicare services from Dr. Burger across 5 procedure codes in 2024, for 114 Medicare patients. Medicare paid $14,669 for them. Every service was in an office.

CMS counts 114 Medicare patients who saw Dr. Burger in 2024. The largest group is 65 to 74, with 59 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 2.24, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Burger's median patient age at 68, with 71% women.

In 2024, Dr. Burger wrote 1,384 Medicare Part D claims for 88 patients. 64% of them were for generic drugs. CMS names the drug for 1,215 of them, across 21 drugs with 11 or more claims each, at $7,329,854 in total drug cost. In 2023, CMS named 1,437 claims across 24 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Burger for performance year 2024, reported as part of a group. Dr. Burger accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Burger as offering telehealth.

Dmand AI links 121 papers to Dr. Burger, published from 2009 to 2025. 2018 was the busiest year, with 8. The most frequent topics are Hypertension, Pulmonary, COVID-19 and Pulmonary Arterial Hypertension. Dr. Burger has published most often in Mayo Clin Proc. Dr. Burger's most frequent co-authors are Robert Eugene Safford, MD, Augustine S. Lee, MD and Scott A. Helgeson, MD.

Dmand AI links Dr. Burger to 27 clinical trials, 12 of them phase 3 studies. 6 are still active or recruiting. Conditions studied include Hypertension, Pulmonary, Pulmonary Arterial Hypertension and Hypertension. United Therapeutics sponsors the most, 7. Open Payments lists research payments to Dr. Burger that name 1 trial.

CMS Open Payments shows 357 general payments to Dr. Burger from 12 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 81% of the total. Actelion Pharmaceuticals US, Inc. paid the most, $86,065. It also lists 7 research payments totaling $2,289 from 2018 to 2019, naming 1 clinical trial.

Dmand AI lists 19 awards for Dr. Burger, most recently Top Doctor in 2025. Dr. Burger serves on Pulmonary Hypertension Association Registry (PHAR) Steering Committee.

Dr. Burger graduated from Wake Forest School of Medicine in 1985. Dr. Burger is a member of ACCP, SCCM and ATS.

Dr. Burger is in network with 8 carriers, including Elevance, Excellus BlueCross BlueShield and United Healthcare. HMO plans come from the most carriers, 4. Check the plan with the practice before a visit.